Canadian Society of Pharmacology and Therapeutics (CSPT)

Log in

Canadian Society of

Pharmacology and Therapeutics

CSPT Endorsed Publications

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

Clinical Practice Guideline: CYP2D6 Genotyping for Safe and Efficacious Codeine Therapy

Recommendations for HLA-B*15:02 andHLA-A*31:01genetic testing to reduce the risk of carbamazepine induced hypersensitivity reactions

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

Pharmacogenomic Declaration

Canadian Society of Pharmacology and Therapeutics (CSPT)

Let's connect: Email | X(Twitter) | Facebook | LinkedIn

Powered by Wild Apricot Membership Software